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 air as reservoir of infections, 715--716

 decorative water features in, 695, 717
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Diphtheria, in HCP, postexposure prophylaxis for, 745
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 cystoscopes as, 629--630

 duodenoscopes as, 610, 621--622

 emerging pathogens as, 631
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Distribution, as water management priority, 692--696. See also *Water distribution.*
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 of infection prevention and control, 581--583
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 water safety and, 700
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 of patient-care items, 622

EVS (environmental services) personnel, role in surface cleaning, 642--643, 647--648

Expenses, in IPCC budget, 576--577

Exposure risk, calculation of, 578--579
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Exposures, in HCP, postexposure prophylaxis for, 735--747, 750. See also *Postexposure prophylaxis (PEP).*

 pre-exposure interventions for, 731, 733--735. See also *Pre-exposure interventions.*
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Fabrics, furniture, safe designs of, 720--721

Failure, in disinfection and sterilization, of patient-care items, 621

 patient risk with, 622, 624

 protocol for exposure investigation after, 624, 628

FDA. See *Food and Drug Administration (FD).*

First aid, as postexposure prophylaxis, in HCP, 736

Fiscal analysis, as IPCC role, 583

Floors, safe designs of, 721

Fluid administration, safe practices for, 798

Fluorescent markers, in surface cleaning monitoring, 644, 646--647

Focused surveillance, 578

Food and Drug Administration (FD), on disinfection and sterilization of medical devices, 610, 621--622, 628--629

Food preparation, infection risks from, 693

Funding, for IPCC, 581--583

Fungus, EOC as source of, 714--715

 outbreak in health care settings, 676--677

Furnishings, safe designs of, 720--721
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Gastroscopes, disinfection and sterilization of, 609--610, 618, 621--622

Genotyping, of outbreaks, 670--671

GlideRite rigid stylets, 631

GlideScope video laryngoscope system, portable, 630--631

Gloves, for HCP, in nursing homes, 790

 in hand hygiene, 599

Glutaraldehyde, for patient-care item sterilization, 614, 624, 628, 630

Government agencies. See also *specific agency or department.*

 influence on IPP, 568--570

 in developing countries, 812--814

Gowns, for HCP, in nursing homes, 790

Group A streptococcus, in HCP, work restrictions for, 749
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HAI identification, antibiotic-resistant bacteria and, informatics for, 765--766

 as outbreak source, 662--664

 in developing countries, 807, 812

HAIs. See *Health care-associated infections (HAIs).*

Hand antisepsis, in hand hygiene, 593

Hand hygiene (HH), **591--607**

 adherence to, 596--598

 barriers to, 598--599

 improving, 600--601

 alcohol-based hand rubs, 593--594, 596, 598--600

 as targeted strategy, 569--570

 CDC guidelines/indications for, 593--595

 definition of, 593

 environmental hygiene and, 651--653

 evolution of guidelines for, 593--594

 HAIs prevention with, 591--592, 601--602

 handwashing stations and, 720

 human skin and skin flora in, 592--593

 in developing countries, 810

 introduction to, 591

 key points of, 591

 summary of, 602--603

 terms for, 592--593

Hand hygiene events, monitoring of, 598

Hand rub, in hand hygiene, alcohol-based, 593--594, 596, 598--600

 for nursing homes, 789--790

 surgical, 593

Handles, of laryngoscopes, HAIs linked to, 630--631

Handwashing, in hand hygiene, 592--593

Handwashing stations, in health care facilities, as transmission risk, 716--717

 safe designs of, 720

HAV. See *Hepatitis A (HAV).*

HBV. See *Hepatitis B (HBV).*

HCP. See *Health care personnel (HCP).*

HCV. See *Hepatitis C (HCV).*

Health care epidemiologist, antimicrobial stewardship role of, 775

Health care facilities/settings, alternative, **785--804**. See also *Alternative health care settings.*

 designing for patient safely and infection prevention, **713--728**. See also *Design of health care facilities.*

 disinfection and sterilization in, **609--637**. See also *Disinfection and sterilization.*

 environmental hygiene of, **639--660**. See also *Environmental hygiene.*

 future design trends for, 721

 informing for development guidelines, 721--722

 infection control in. See *Infection control program.*

 infection prevention in. See *Infection prevention program (IPP).*

 occupational health for, 730. See also *Occupational health.*

Health care personnel (HCP), as infection source, 714

 as outbreak source, 672

 cleaning patient-care items, 622

 hand hygiene education for, 600

 in developing countries, education strategies for, 813--814

 in nursing homes, infection prevention education for, 795

 occupational health for, **729--757**. See also *Occupational health.*

 professional role of, in hand hygiene, 599--600

 protection of, as IPP goal, 568

Health care practices, optimal, reimbursement and, 568--569, 582--583

Health care reform, for nursing homes, 787, 795--796

 paradigm shift in infection programs, 569

Health care workers. See *Health care personnel (HCP).*

Health care-associated infections (HAIs), environmental transmission of. See also *Health care facilities/settings.*

 epidemiology of, 639--641

 hygiene prevention of, **639--660**. See also *Environmental hygiene.*

 reducing, 622--624. See also *Disinfection; Sterilization.*

 hand hygiene prevention of, 591--592, 601--602

 identification of. See *HAI identification.*

 in low-income and middle-income countries, **805--818**. See also *Developing countries.*

 most common types of, 568

 prevalence surveys of, 567--568

 prevention programs for. See *Infection control program; Infection prevention program (IPP).*

 surveillance of. See *Surveillance entries.*

 targeted categories of, 569--570

 water-based. See *Water safety.*

Health status, HAIs impact on, in developing countries, 806, 812

Heater-cooler devices, infection risks from, 694

Heating systems, safe design of, 718--719

Hemodialysis, infection risks from, 569, 693

Hemodialysis centers, infection prevention programs in, 796

HEPA (high-efficiency particulate air) filters, 720

Hepatitis A (HAV), in HCP, immunization for, 735

 postexposure prophylaxis for, 745--746

 work restrictions for, 748

 outbreak investigations of, 665

Hepatitis B (HBV), in HCP, immunity proof for, 733

 immunization for, 731, 733--734

 special use of, 733--735

 postexposure prophylaxis for, 739--740

 work restrictions for, 748

 outbreak investigations of, 666, 798

Hepatitis C (HCV), in HCP, work restrictions for, 748

 outbreak investigations of, 666

Herpes simplex, in HCP, work restrictions for, 748

Herpes virus, outbreak investigations of, 666

HH. See *Hand hygiene (HH).*

High-efficiency particulate air (HEPA) filters, 720

High-level disinfection (HLD), agents and methods for, 613--617

 of patient-care items and environmental surfaces, 610--611, 613, 617--618, 621--622, 628, 630--631. See also *Ultraviolet (UV) light.*

High-risk settings, for infection outbreaks, 678--680

HIV. See *Human immunodeficiency virus (HIV).*

Hospital administration, antimicrobial stewardship role of, 776

Hospital environment. See also *Environment entries.*

 as infection source, criteria evaluating strength of evidence for, 714--715

 as outbreak source, 672

 role in transmission, 622--627

Hospital physician epidemiologist, as IPCC member, 571--573

 environmental monitoring role of, 648

 primary responsibilities of, 573

Hospital rate of infection, 570, 578

 calculation of, 578--579

Hospital-acquired conditions (HACs), as infection reduction target, 569

 economic impact of, 581--582

 in developing countries, 805--806

 value-based purchasing and, 582--583

Hospital-acquired infections. See *Health care-associated infections (HAIs).*

HP. See *Hydrogen peroxide entries.*

Human bites, postexposure prophylaxis for, 746

Human immunodeficiency virus (HIV), postexposure prophylaxis for, 739, 741

 work restrictions for, 748

Human papilloma virus, as health care facility issue, 624, 628

 environmental transmission of, 631, 649

Human skin, hand hygiene and, 592--593

Human waste disposal, in design of health care facilities, 720

HVAC systems, safe design of, 718--719, 721

Hydrogen peroxide (HP) gas plasma, for patient-care item disinfection, improved, 619

 for patient-care item sterilization, 613--614, 616

 improved, 615

 ozone and, 617

 vaporized, 616

Hydrogen peroxide mist system for probes, 628--629

Hydrogen peroxide (HP) systems, for environmental surface disinfection, 648

 for laryngoscope disinfection, 630

 for room decontamination, 624

 advantages vs. disadvantages of, 624, 627

 clinical trials on, 624--626

 UV light vs., 624

Hydrotherapy, infection risks from, 693

Hygienic practice, continuum of, 651--652

 elements of, 651--652

 horizontal healthcare, 640--641

 interventions for, 651, 653

 evaluation cleanliness based on, 655

 sequential, 601

 research agenda for, 654

Hypothesis analysis, of risk factors, for outbreaks, 663
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ICAT (infection prevention and control assessment tools), for developing countries, 812

Ice machines, infection risks from, 693, 716

ICRA (infection control risk assessment), 715, 718, 722

Immersion of channel scopes, for disinfection and sterilization, 629--630

Immunity, proof of, in HCP, 731, 733

Immunizations, as pre-exposure intervention, for HCP, contraindications to, 735

 immunity proof vs., 731, 733

 recommendations for, 731--732, 734

 special use, 734--735

Immunocompromised personnel, immunizations for, 733

Incident report, for postexposure prophylaxis, in HCP, 736

Infection control program, antimicrobial stewardship in, **771--784**. See also *Antimicrobial stewardship.*

 as team member, 776--780

 in health care facilities. See also *Infection prevention program (IPP).*

 alternative settings for, **785--804**

 building a successful, **567--589**

 in low-income and middle-income countries, **805--818**. See also *Developing countries.*

 informatics in, **759--770**. See also *Informatics.*

 background on, 759--760

 efficacy of, 759--760

 implementing software for, 766--768

 infection prevention and, 759, 764--766

 infection surveillance and, 759--764

 key points of, 759

 public health and, 766

 summary of, 768

 term description for, 759

Infection control risk assessment (ICRA), 715, 718, 722

Infection control risk mitigation recommendations (ICRMR), 718

Infection precautions. See *Isolation precautions.*

Infection prevention and control assessment tools (ICAT), for developing countries, 812

Infection prevention and control committee (IPCC), in health care facilities, authority of, 571

 budget preparation by, 575--577

 key members of, 571--575

 management styles effect on, 574--575

 meeting management strategies for, 574, 576

 multidisciplinary members of, 571, 581

 primary responsibilities of, 572

 review of surveillance findings, 571--572

Infection prevention program (IPP), in health care facilities, alternative settings of, **785--804**. See also *Alternative health care settings.*

 ambulatory care centers as, 569, 796--799

 background on, 785, 799

 nursing homes as, 786--796

 antimicrobials in, **771--784**. See also *Antibiotics; Antimicrobial entries.*

 designing for patient safety, **713--728**. See also *Design of health care facilities.*

 disinfection and sterilization in, **609--637**. See also *Disinfection; Sterilization.*

 environmental hygiene of, **639--660**. See also *Environmental hygiene.*

 hand hygiene in, **591--607**. See also *Hand hygiene (HH).*

 informatics in, **759--770**. See also *Informatics.*

  *Legionella pneumophilia and,* **689--712**. See also *Legionella pneumophilia; Water entries.*

 occupational health in, **729--757**. See also *Occupational health.*

 of low-income and middle-income countries, **805--818**. See also *Developing countries.*

 outbreak investigations in, 579--580, **661--687**. See also *Outbreaks.*

 successful for HAIs prevention, **567--589**. See also *Health care-associated infections (HAIs).*

 components of, 570--572

 budget as, 575--577, 583

 business plan as, 581--583

 committee as, 571--572

 mission, vision, and values as, 570--571

 outbreak investigations as, 579--580, 661

 quality improvement as, 581

 surveillance as, 576--579

 team members as, 572--575

 current initiatives for, 568--569

 economics and, 581--583, 774, 779--780

 in developing countries, 805--806

 evolution of regulation and requirements for, 567--570

 in alternative health care settings, **785--804**. See also *Alternative health care settings.*

 key points of, 567

 major goals of, 568

 summary of, 583

 team for, committee in, 571--572

 key members of, 572--575

 team meeting management in, 574--576

 team members for, 572--575

 administrative assistant as, 571, 573

 data programmer and analyst, 571--573

 hospital physician epidemiologist as, 571--573

 infection prevention staffing as, 571, 574--575

 infection preventionist as, 571, 573--574, 581

 medical director of infection prevention as, 571--573

Infection prevention staffing, as IPCC member, 571, 574--575

Infection preventionist (IP), activities reported by, 577

 electronic via informatics, 766

 antimicrobial stewardship role of, 775--776. See also *Antimicrobial stewardship.*

 as IPCC member, 571, 573--574, 581

 ICRA developed by, 715

 in nursing homes, 794--795

 management styles of, 574--575

 nursing home role of, 786--796

 primary responsibilities of, 574

Infection rate, in developing countries, 807--808

 in hospital, 570, 578

 calculation of, 578--579

 in nursing homes, 792--793

Infection risk, as high, in nursing homes, 793

 from critical items for patient-care, 613

 from water uses, 692--694

 in hospital environment, criteria for evaluating, 714--715

 of outbreaks, 672--674

 nosocomial, 568, 806. See also *Health care-associated infections (HAIs).*

Infectious diseases physician, antimicrobial stewardship role of, 774--775

Influenza, immunity proof for, 733

 immunization for, 731, 733--734

 special use of, 733--735

 in developing countries, 808

 postexposure prophylaxis for, 747, 750

Informatics, in infection control, **759--770**

 background on, 759--760

 efficacy of, 759--760

 implementing software for, 766--768

 infection prevention and, 759, 764--766

 admission recognition of MDROs, 764--765

 antibiotic stewardship, 765--766

 identification of inappropriate precautions, 765

 reduction of device use, 765

 infection surveillance and, 759--764

 data sources for, 761

 fully automated vs. semiautomated, 761

 outbreak detection with, 764, 766

 subjective vs. objective, 579, 760--761

 key points of, 759

 medical, for surveillance, 579

 metric enhancement with, 761--764

 for *C difficile,* 760--762, 764

 for catheter-associated urinary tract infections, 762--764

 for central line--associated bloodstream infections, 761--762

 for multidrug-resistant organisms, 762, 764

 for surgical site infections, 762--763

 for ventilator-associated pneumonia, 762--763

 public health and, 766

 summary of, 768

 term description for, 759

Informatics software, implementing, 766--768

 data validation in, 767--768

 device data challenges in, 767

 general considerations for, 766

 microbiology data challenges in, 767

Information technology. See also *Computer science.*

 antimicrobial stewardship role of, 775

Inherent behavior, in hand hygiene, 600

Injection practices, safe, in ambulatory care centers, 798

 in nursing homes, 791

Instrument asepsis, in ambulatory surgical centers, 797--798

Instrument design, in endoscope reprocessing, 621

Intensive care unit (ICU), designs for patient safety and infection prevention, 716, 720--721

 hand hygiene in, 598, 600--601

 in developing countries, 806, 810--811, 813

Intravenous therapy, safe practices for, 798

Iodophors, for patient-care item disinfection, 620

IP. See *Infection preventionist (IP).*

IPCC. See *Infection prevention and control committee (IPCC).*

IPP. See *Infection prevention program (IPP).*

Isolation precautions, in ambulatory care centers, 796--797

 in nursing homes, 791--792

 inappropriate, informatics identification of, 765

Isolation room, for airborne infection, 719--720, 796
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*Klebsiella pneumoniae,* outbreak investigations of, 666

 water safety and, 700
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Labor expenses, in IPCC budget, 576--577

Laboratory, microbiology, antimicrobial stewardship role of, 775

Laboratory tests, for outbreaks, in health care settings, 670--671

Laryngoscope blades, HAIs linked to, 630

 storage issues of, 629

Laryngoscopes, disinfection and sterilization of, 630--631

LD pneumonia, building water distribution systems and, 701

 description of, 697

 unapparent or creeping outbreak of, 702--703

Leak testing, of endoscopes, for disinfection and sterilization, 618

*Legionella pneumophilia,* water safety and, in health care, **689--712**

 building water safety plans for, 703--705

 decision points for, 703--704

 infections prevention plan in, 704--705

 stakeholders in, 704--705

 team approach to, 703--704

 future of, 706

 introduction to, 690--691

 key points of, 689

 outbreak investigations of, 666, 673--674

 pathogens and, 690--703

 transmission routes of, 690--691

 pneumonia and, building water distribution systems in, 701

 description of, 697

 unapparent or creeping outbreak in, 702--703

 summary of, 706

 water distribution systems and, 690--691

 water management priorities for, 691--696

 conservation as, 696

 distribution and quality as, 692

 emergency security as, 696

 safety as, 692--696

 water uses and infection risks of, 692--694

 water-based HAIs and, 696--703

  *Acinetobacter sp.* as, 699

  *E coli* as, 700

  *Enterobacteriaceae sp.* as, 700

  *Klebsiella sp.* as, 700

  *Legionella sp.* as, 696--698, 701--703

  *Mycobacterium sp.* as, 698

 NTM as, 690--691, 698

 other gram-negative pathogens as, 700

  *Pseudomonas aeruginosa* as, 690--691, 699

 scope of, 696--697

  *Stenotrophomonas maltophilia* as, 699

Legislation, on health care reform, effect on infection programs, 569

Level of care, in nursing home settings, information transfer during transitions of, 788--789

*Listeria monocytogenes,* outbreak investigations of, 667

Low-income and middle-income countries (LMIC), preventing HAIs in, **805--818**. See also *Developing countries.*

Low-level disinfection (LLD), of patient-care items and environmental surfaces, 610, 612--613
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Management strategies, for IPCC meetings, 574, 576

Management styles, in IPCC meetings, 574--575

McGrath video laryngoscope system, 630

MDROs. See *Multidrug-resistant organisms (MDROs).*

Measles, in HCP. See also *Rubella.*

 immunity proof for, 733

 immunization for, 731, 733--734

 special use of, 733--735

 postexposure prophylaxis for, 745

 work restrictions for, 748

Mechanical (no-touch) methods, for environmental surface disinfection, 649

 for room decontamination, 623

Medical director of infection prevention, as IPCC member, 571--573

 primary responsibilities of, 573

Medical informatics, for surveillance, 579. See also *Informatics.*

Medication preparation, infection risks from, 693

Medication therapies, optimizing patient outcomes with, 773--774. See also *Antimicrobial stewardship.*

Meningococcal infections, in HCP, immunization for, 731, 733--734

 special use of, 733--735

 postexposure prophylaxis for, 741--742

 work restrictions for, 748

Methicillin-resistant *Staphylococcus aureus* (MRSA), antimicrobial stewardship and, 772

 as targeted infection, 569--570

 environmental transmission of, 622--624, 641, 644

 in HCP, work restrictions for, 749

 in nursing homes, 787----791

 outbreak investigations of, 676

Microbiology, of outbreaks, in health care settings, 670

Microbiology data, informatics software challenges with, 767

Microbiology laboratory, antimicrobial stewardship role of, 775

Microorganisms. See *Pathogens.*

Middle-income countries, preventing HAIs in, **805--818**. See also *Developing countries.*

Ministries of Health, in developing countries, 812

Miscellaneous expenses, in IPCC budget, 576--577

Mission statement, of IPPs, 570

Mist system for probes, hydrogen peroxide, 628--629

Mold, outbreak in health care settings, 676--677

Molecular testing, of outbreaks, 670

MRSA. See *Methicillin-resistant Staphylococcus aureus (MRSA).*

Multidisciplinary bundles, in antimicrobial stewardship, 777--778

Multidisciplinary team, for antimicrobial stewardship, 774--776

 for infection prevention and control, 571, 581

Multidrug-resistant organisms (MDROs), antimicrobial stewardship for, 772--773

 as targeted infection, 570, 578, 621, 631

 economic impact of, 581--582, 774

 environmental transmission of, 622--623, 641, 714

 in nursing homes, 768--788, 790--794

 informatics recognition during admission, 764--765

 informatics surveillance of, 762, 764

 rate calculation of, 579

Multilocus sequence typing (MST), of outbreaks, 671

Mumps, in HCP, immunity proof for, 733

 immunization for, 731, 733--734

 special use of, 733--735

 work restrictions for, 749

*Mycobacterium chelonea,* 631

*Mycobacterium terrae,* 628--629

*Mycobacterium tuberculosis,* 631

 in HCP, work restrictions for, 749

 outbreak investigations of, 667

 water safety and, 698
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National Healthcare Safety Network (NHSN), antimicrobial stewardship and, 780

 as surveillance data source, 573, 578

Natural disasters, HAI prevention after, in developing countries, 810

Needlestick injuries. See also *Safe injection practices.*

 postexposure prophylaxis for, 731, 737--739

 reduction methods for, 738

Negative pressure room, in ambulatory care centers, 796

Neonatal intensive care unit (NICU), as high-risk setting for outbreaks, 678--679

NHs. See *Nursing homes (NHs).*

Noncritical items, disinfection and sterilization of, 612, 617--620

Nonpotable water (process water), safety issues of, 692, 695--696, 716

Nontuberculous mycobacteria (NTM), outbreak investigations of, 667, 674

 water safety and, 690--691, 698

Norovirus, as targeted infection, 631

Nosocomial infections, 568, 806. See also *Health care-associated infections (HAIs).*

No-touch (mechanical) methods, for environmental surface disinfection, 649

 for room decontamination, 623

Numerators, in hospital rate of infection, 579

Nursing homes (NHs), infection prevention programs in, 786--796

 CAUTIs in, 787

 components of, 787

 employee health programs and, 794

 environmental hygiene for, 794

 environmental rounds for, 795

 evolution of, 786

 functions of, 787

 hand hygiene for, 787, 789--790

 infection preventionist role in, 794--795

 information transfer during care transitions, 788--789

 isolation precautions for, 791--792

 MDROs and, 768--788, 790--794

 MRSA in, 787----791

 outbreak management for, 791--793

 oversight of, 787--788, 795--796

 protocol bundles for, 787--789

 rehabilitation services and, 793--794

 resident health programs and, 794

 resources for, 787--788

 safe injection practices for, 791

 staff education on, 795

 surveillance for, 792--793
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Occupational health, infection prevention in, **729--757**

 components of, 731--732

 definitions for, 730--732

 health care personnel covered by, 730

 health care settings included in, 730

 ill health care personnel evaluations for, 748--750

 in developing countries, 809--810

 in nursing homes, 794

 introduction to, 729--730

 key points of, 729, 732

 postexposure prophylaxis for, 732, 735--747, 750

 animal bites, 746--747

 counseling in, 736--737

 diphtheria, 745

 ectoparasites, 747

 general guidelines of, 735--736

 hepatitis A, 745--746

 hepatitis B, 739--740

 human bites, 746

 human immunodeficiency virus, 739, 741

 influenza, 747, 750

 measles, 745

 meningococcal infections, invasive, 741--742

 pertussis, 743--744

 protocol for, 736

 rabies, 746--747

 sharps injuries in, 731, 737--739

 syphilis, 747

 tetanus, 744

 varicella, 742--743

 pre-exposure interventions for, immunizations as, 731, 733--735

 contraindications to, 735

 immunity proof vs., 731, 733

 recommendations for, 731, 734

 special use, 734--735

 screening as, 731--732

 professional guidelines for, 731

 scope of programs, 731

 work restrictions for health care personnel, 732, 748--750

Occupational Health and Safety Administration (OSHA), 731

Occupational health services (OHSs), 730--731

Occupational therapy (OT), in nursing homes, infection prevention for, 793--794

OPA (ortho-phthalaldehyde), for patient-care item sterilization, 614, 624, 628

Optical mapping, of outbreaks, 671

Ortho-phthalaldehyde (OPA), for patient-care item sterilization, 614, 624, 628

Outbreaks, in health care settings, **661--687**

 approach to, 662--670

 definitions of, 662--663

 delay in identification of, 662

 diagnosis verification for, 662--663

 high-risk settings for, 678--680

 endoscopy suites as, 679--680

 NICU as, 678--679

 transplant units as, 680

 hospital unit closures due to, 662

 hypothesis analysis of risk factors for, 663

 specific organism exposures in, 664--669

 impact on patients, 662

 informatics detection of, 764, 766

 introduction to, 661--662

 investigations of, case definition for, 662--663

 communication importance during, 670

 exposure risk factor analysis in, 664--669

 laboratory and testing in, 670--671

 primary components in, 579--580, 662--663, 670

 source identification in, 662--664

 key points of, 661

 LD pneumonia as, 702--703

 measures to stop, 663, 670

 nursing homes as, 793

 of SARS, 662, 677

 organisms in, 674--678

  *Acinetobacter sp. as,* 664, 674--675

 adenovirus as, 664

  *Aspergillus sp.* as, 664, 676--677

  *C difficile* as, 671, 678

  *Campylobacter fetus.* as, 665

  *Candida sp.* as, 664

 carbapenem-resistant *Enterobacteriaceae* as, 675--676

 coronaviruses as, 677

  *E coli.* as, 665

  *Enterobacter sp. as,* 665, 678

 exposure risk analysis of, 664--669

 fungus as, 676--677

 gastrointestinal infections as, 665, 668, 678

 hepatitis A, B, and C as, 665--666, 798

 herpes virus as, 666

 influenza A and B as, 677

  *Klebsiella pneumoniae as,* 666

  *Legionella sp. as,* 666, 673--674

  *Listeria monocytogenes . as,* 667

 MERS as, 677

 mold as, 676--677

 MRSA as, 676

  *Mycobacterium tuberculosis. as,* 667

 nontuberculous mycobacteria as, 667, 674

 pertussis as, 677--678

  *Pseudomonas sp. as,* 667, 675

  *Ralstonia pickettii as,* 667

 respiratory infections as, 662, 666, 677

 rotovirus as, 662

  *S aureus* as, 668--669, 671, 676

  *Salmonella sp. as,* 667

 SARS as, 662, 677

  *Serratia marcescens as,* 668

  *Streptococcus pyogenes as,* 669

 varicella as, 669

  *Yersinia enterocolitica as,* 669

 pseudo-outbreaks vs., 670

 sources of, 672--674

 health care personnel as, 672

 hospital environment as, 672

 identification of, 662--664

 waterborne, 672--674

 summary of, 680

Outcome measures, of aseptic practices, in ambulatory surgical centers, 797--798

Outpatient settings, for health care. See *Ambulatory care centers; specific service or type.*

Oversight committee, for infection control, in nursing homes, 787--788, 795--796

 for nursing homes, 787--788, 795--796

P {#sec15}
=

Parasite infestations, postexposure prophylaxis for, 747

Partnerships, for capacity building, in developing countries, 811--812

Pathogens. See also *specific microorganism.*

 bloodborne, 568

 in nursing homes, 791--792

 occupational health regulations for, 731

 emerging, as health care facility issue, 631

 EOC as source of, 714--716

 ESKAPE, 772

 outbreak investigations of, 663

 exposure risk analysis of, 664--669

 organisms in, 674--678

 resistance to antimicrobials. See *Antibiotic-resistant bacteria.*

 water-based. See *Waterborne pathogens.*

Patient outcomes, with medication therapies, strategies for optimizing, 773--774. See also *Antimicrobial stewardship.*

Patient risk, from disinfection and sterilization failures, as health care facility issue, 621--622, 624

 protocol for exposure investigation after, 624, 628

Patient role, in hand hygiene, 600

Patient safety, designing health care facilities for, **713--728**. See also *Design of health care facilities.*

Patient safety initiatives, as IPP goal, 568

Patient-care items, disinfection and sterilization of, critical items, 613--617

 in ambulatory surgical centers, 797--798

 noncritical items, 612, 617--620

 semicritical items, 611--617

 disinfection methods for, 610--613

 sterilization methods for, 610--611, 613

Patient-care rooms, as infection transmission risk, 717--718

 cleaning of. See *Discharge cleaning; Room decontamination.*

 safe design of, 719--720, 796

PE (protective environment) room, 720

PEP. See *Postexposure prophylaxis (PEP).*

Peracetic acid, for environmental surface disinfection, 648

 for patient-care item sterilization, 615

Peracetic acid/HP, for environmental surface disinfection, 648

 for patient-care item disinfection, 620

 for patient-care item sterilization, 614

Performance feedback, in hand hygiene, 600--601

Perfusion of channel scopes, for disinfection and sterilization, 629--630

Pertussis, in HCP, immunity proof for, 733

 immunization for, 731, 733--734

 special use of, 733--735

 postexposure prophylaxis for, 743--744

 work restrictions for, 749

PFGE (pulse field gel electrophoresis), for outbreaks, 671

Phage typing, of outbreaks, 670

Pharmacist, clinical, antimicrobial stewardship role of, 775

Pharmacy. See also *Medication therapies.*

 infection risks from, 693

Pharmacy and therapeutics (P & T) committee, antimicrobial stewardship role of, 776

Phenolics, for patient-care item disinfection, 620

Physical Self Maintenance Score (PSMS), 790

Physical therapy (PT), in nursing homes, infection prevention for, 793--794

Physician epidemiologist. See *Hospital physician epidemiologist.*

Physicians, hand hygiene in, 599, 601

Plain soap, in hand hygiene, 592--593

Plasmid typing, of outbreaks, 670

Pneumonia. See *LD pneumonia; Ventilator-associated pneumonia (VAP).*

Poliomyelitis, immunization for, 735

Polymerase chain reaction (PCR), for outbreaks, 671

Postexposure prophylaxis (PEP), for HCP, 732, 735--747, 750

 animal bites, 746--747

 counseling in, 736--737

 diphtheria, 745

 ectoparasites, 747

 general guidelines of, 735--736

 hepatitis A, 745--746

 hepatitis B, 739--740

 human bites, 746

 human immunodeficiency virus, 739, 741

 illness evaluation and, 750

 influenza, 747, 750

 meningococcal infections, invasive, 741--742

 pertussis, 743--744

 protocol for management, 736

 rabies, 746--747

 sharps injuries in, 737--739

 syphilis, 747

 tetanus, 744

 varicella, 742--743

 work restrictions and, 748--750

Precautions, infection, in ambulatory care centers, 796--797

 in nursing homes, 791--792

 inappropriate, informatics identification of, 765

Pre-exposure interventions, for HCP, 731, 733--735

 immunizations as, 731, 733--735

 contraindications to, 735

 immunity proof vs., 731, 733

 recommendations for, 731, 734

 special use, 734--735

 screening as, 731--732

Pregnant personnel, immunizations for, 734--735

Prevalence surveys, of HAIs, 567--568

Probes, hydrogen peroxide mist system for, 628--629

Process education, on disinfection and sterilization, in ambulatory surgical centers, 797--798

 of patient-care items, 622

Process (nonpotable) water, safety issues of, 692, 695--696, 716

Product consumption evaluation, in hand hygiene compliance, 597--598, 601

Product education, in hand hygiene, 600

Professional role, of NCP, in hand hygiene, 599--600

Professional societies, business analyses framework of, 582--583

 immunization recommendations of, 731

 influence on IPP, 568

 occupational health recommendations of, 735

 on ambulatory surgical center programs, 797--798

 on antibiotic resistance, 790--791

 on designing health care facilities, 717--722

 support of automated surveillance technologies, 579

Protection, of health care workers, as IPP goal, 568

Protective environment (PE) room, 720

Protocol bundles, in developing countries, 811

 in nursing homes infection prevention programs, 787--789

*Pseudomonas sp.,* environmental transmission of, 641

 outbreak investigations of, 667, 675

 water safety and, 690--691, 699

Pseudo-outbreaks, in health care settings, 670

PSMS (Physical Self Maintenance Score), 790

PT (physical therapy), in nursing homes, infection prevention for, 793--794

Public health, informatics and, 766

Public water utilities, 690

Pulse field gel electrophoresis (PFGE), for outbreaks, 671
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Quality, as water management priority, 692--696

Quality improvement, as infection preventionist role, 581

Quaternary ammonium compounds, for patient-care item disinfection, 620
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Rabies, immunization for, 735

 postexposure prophylaxis for, 746--747

Radiofrequency tracking, in hand hygiene compliance, 598

*Ralstonia pickettii,* outbreak investigations of, 667

Random amplification of polymorphic DNA (RAPD), of outbreaks, 671

Rate of infection. See *Infection rate.*

Rational approach, to health care facilities disinfection and sterilization, 610--613

Regulatory bodies. See *Government agencies.*

Rehabilitation services, in nursing homes, infection prevention for, 793--794

Reimbursement, as regulatory leverage, 568--570

 value-based purchasing and, 582--583

Renovation, of health care facilities, for patient safely and infection prevention, **713--728**. See also *Design of health care facilities.*

Reporting, of postexposure prophylaxis, for HCP, 736

 of surveillance data, electronic via informatics, 577, 766

 voluntary vs. regulatory, 568--570

Reprocessing, of scopes. See *Endoscope reprocessing.*

Resident health programs, in nursing homes, 794

Resources, for infection control programs, design of health care facilities and, 722

 in developing countries, as limited, 807

 building capacity through partnerships, 811--812

 identification of, 807, 812

 prioritization of, 813--814

 successful interventions despite, 810--811

 successful examples of, 810--811

 in nursing homes, 787--788

Respiratory equipment, infection risks from, 694

Respiratory hygiene, in ambulatory care centers, 796--797

Respiratory tract infections, in developing countries, 812

  *Legionella pneumophilia* as, **689--712**. See also *LD pneumonia.*

 outbreaks of, in health care settings, 662, 666, 677

 tuberculosis as. See *Mycobacterium tuberculosis.*

 ventilator-related. See *Ventilator-associated pneumonia (VAP).*

 viral, in HCP, work restrictions for, 749

Restriction fragment length polymorphisms (RFLP), of outbreaks, 671

Retrospective surveillance, 577--578

Reuse, of single-use devices, 629, 798

 of single-use instruments, in ambulatory surgical centers, 797--798

Ribotyping, of outbreaks, 671

Risk factors, hypothesis analysis of, for outbreaks, 663

Risk of infection. See *Infection risk; Patient risk.*

RNA probe, for outbreaks, 671

Room decontamination, advantages vs. disadvantages of, 624, 627

 clinical trials on, 624--626

 comparison of methods for, 624

 effectiveness in reducing HAIs, 622--623

 hydrogen peroxide systems for, 624

 in ambulatory surgical centers, 797--798

 no-touch (mechanical) methods for, 623

 ultraviolet light for, 623--624

Rooms. See *Patient-care rooms; specific design.*

Route selection, for drugs, in antimicrobial stewardship, 773--774

Rubella, in HCP, immunity proof for, 733

 immunization for, 731, 733--734

 special use of, 733--735

 work restrictions for, 749

S {#sec18}
=

Safe injection practices, in ambulatory care centers, 798

 in nursing homes, 791

Safety, as water management priority, 692--696. See also *Water safety.*

 of patients. See *Patient safety initiatives.*

Safety margin, in disinfection and sterilization, 621, 624, 628

*Salmonella sp.,* outbreak investigations of, 667

Scopes, reprocessing of. See *Endoscope reprocessing.*

Screening, pre-exposure, of HCP, 731--732

 in developing countries, 809--810

Security, as water management priority, 696

Self-disinfecting surfaces, 649--650

Self-protection behavior, in hand hygiene, 599

Semicritical items, disinfection and sterilization of, 611--617

 storage issues of, 613, 629

SENIC (Study on the Efficacy of Nosocomial Infection Control), 568, 571, 575

Sequential interventions, for hand hygiene improvement, 601

Serotyping, of outbreaks, 670

*Serratia marcescens,* outbreak investigations of, 668

Sharps injuries. See also *Safe injection practices.*

 postexposure prophylaxis for, 731, 737--739

 reduction methods for, 738

SHEA. See *Society for Healthcare Epidemiology of America (SHEA).*

Single locus sequence typing (SLST), of outbreaks, 671

Single-occupancy patient-care rooms, 719--720

Single-use devices, reuse of, 629, 798

Single-use instruments, in ambulatory surgical centers, 797--798

Sink accessibility, in hand hygiene, 598

Skin flora, hand hygiene and, 592--593

Smallpox, immunization for, 735

Soap, in hand hygiene, antimicrobial, 593

 plain, 592--593

Society for Healthcare Epidemiology of America (SHEA), business analyses framework of, 582--583

 influence on IPP, 568

Sodium hypochlorite, for patient-care item disinfection, 619

Source of outbreaks, in health care settings, 672--674

 health care personnel as, 672

 hospital environment as, 672

 identification of, 662--664

 waterborne, 672--674

Sporicidal agents, for environmental surface disinfection, 648

SSIs. See *Surgical site infections (SSIs).*

Stakeholders, in water safety plans, 704--705

Standard precautions, in nursing homes, 791

Standardized infection rate, 578--579

*Staphylococcus aureus,* antibiotic-resistant. See *Methicillin-resistant Staphylococcus aureus (MRSA).*

 antimicrobial stewardship for, 778

 hand hygiene and, 591

 in developing countries, 811

 outbreak investigations of, 668--669, 671, 676

Steam, for patient-care item sterilization, 616

*Stenotrophomonas maltophilia,* water safety and, 699

Sterilization, in health care facilities, **609--637**. See also *Disinfection and sterilization.*

 agents and methods for, 613--617

 ambulatory surgical centers as, 797--798

 of patient-care items and environmental surfaces, 610--611, 613, 622--624

Storage, of semicritical items, as infection issue, 613, 629

Streptococcus, group A, in HCP, work restrictions for, 749

*Streptococcus pyogenes,* outbreak investigations of, 669

Study on the Efficacy of Nosocomial Infection Control (SENIC), 568, 571, 575

Surface decontamination, in health care facilities, advantages vs. disadvantages of, 624, 627

 clinical trials on, 624--626

 comparisons of methods for, 624

 disinfection methods for, 610--613

 improving, 622--624

 effectiveness in reducing HAIs, 622--623

 sterilization methods for, 610--611, 613

 improving, 622--624

Surface finish, as transmission risk, 717--718

 safe designs of, 720--721

Surgical hand rub, in hand hygiene, 593

Surgical instruments, disinfection and sterilization of, in ambulatory surgical centers, 797--798

Surgical scrub, in hand hygiene, 593

Surgical site infections (SSIs), as targeted HAI, 569--570, 578

 in ambulatory care centers, 797

 informatics surveillance of, 762--763

 rate calculation of, 579

Surveillance, automated technologies for, 579

 fully or semi-, 761

 concurrent, 578

 data sources for, active, 579

 concurrent or retroactive, 577--578

 informatics and, 761

 definition of, 576--577, 760

 in developing countries, gaps and opportunities for, 807--808

 of antimicrobial resistance, 808--809

 in nursing homes, 790, 792--793

 methodologies for, 578--579

 priorities for, 578

 retrospective, 577--578

 subjective vs. objective, 760--761

 syndromic, informatics for, 766

Surveillance activities, reported by infection preventionist, 577, 766

Surveillance data, IPCC review of, 571--572

 reporting of, electronic via informatics, 577, 766

 voluntary vs. regulatory, 568--570

Syndromic surveillance, informatics for, 766

Syphilis, postexposure prophylaxis for, 747

T {#sec19}
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Targeted surveillance, 578

TB. See *Tuberculosis (TB).*

Tdap. See *Pertussis.*

TDC (thoroughness of disinfection cleaning) score, 642--643

Team approach, to infection prevention and control, 571, 581

 to water safety plans, 703--704

Technologies, automated, for surveillance, 579

 fully or semi-, 761

 in hand hygiene compliance, 597--598, 601

 information, 579. See also *Computer science.*

 antimicrobial stewardship role of, 775

 to augment disinfection of surfaces, 649--650

Tetanus, immunization for, 735

 postexposure prophylaxis for, 744

The Joint Commission (TJC), hospital accreditation standards of, 568--570

 on disinfection and sterilization of medical devices, 629

 on isolation precautions, in ambulatory care centers, 797

 on safe design of health care facilities, 718

 surveillance recommendations of, 577

Thoroughness of discharge cleaning, 647

Thoroughness of disinfection cleaning (TDC) score, 642--643

Time savings, with alcohol-based hand rub, 596, 598--599

TJC. See *The Joint Commission (TJC).*

Toilets, in design of health care facilities, 720

Total house surveillance, 578

Transmission role, of hands. See *Hand hygiene (HH).*

 of health care environment, 622--627. See also *Environmental hygiene.*

 of health care personnel, 750

Transmission routes, of waterborne pathogens, 690--691

Transmission-based precautions, in nursing homes, 791--792

Transplant units, as high-risk setting for outbreaks, 680

Treatment protocol bundles, in developing countries, 811

 in nursing homes infection prevention programs, 787--789

Trophon, for endocavity disinfection, 628--629

Tuberculosis (TB). See also *Mycobacterium tuberculosis.*

 in developing countries, prevention of, 809--810

 in HCP, work restrictions for, 749

U {#sec20}
=

Ultraviolet (UV) light, for environmental surface disinfection, 649

 for room decontamination, 623--624

 advantages vs. disadvantages of, 624, 627

 clinical trials of, 624--626

 HP systems vs., 624

Unapparent outbreak, of LD pneumonia, 702--703

Universal patient-care rooms, 719

V {#sec21}
=

Vaccinia, immunization for, 735

Validation, of data, in surveillance, 760--761

 informatics software challenges with, 767--768

Value statement, core, of IPPs, 571

Value-based purchasing, and HACs, 582--583

Vancomycin-resistant *Enterococcus* (VRE), antimicrobial stewardship and, 772

 environmental transmission of, 622--624, 630--631, 641, 644

 in nursing homes, 790--791

VAP. See *Ventilator-associated pneumonia (VAP).*

Varicella, in HCP, immunity proof for, 733

 immunization for, 731, 733--734

 special use of, 733--735

 postexposure prophylaxis for, 742--743

 work restrictions for, 749

 outbreak investigations of, 669

Ventilation systems, safe design of, 718--719

Ventilator-associated pneumonia (VAP), as targeted HAI, 569, 578

 in developing countries, 806--807, 811, 813

 informatics surveillance of, 762--763

Video laryngoscope systems, portable GlideScope, 630--631

Video surveillance, in hand hygiene compliance, 598, 601

Viruses. See also *specific virus.*

 as health care facility issue, 624, 628--629, 631

 surrogate microbes of, 631

 as targeted infection, 593, 631, 640

 environmental transmission of, 622--624

 HCP exposures. See also *Occupational health.*

 work restrictions for, 749

 outbreak investigations of, 662, 664, 666, 677

Vision statement, of IPPs, 570

Visual audits/monitoring, of environment, 642--643

 of hand hygiene compliance, 597--598, 601

 of surface cleaning, 645

VRE. See *Vancomycin-resistant Enterococcus (VRE).*

W {#sec22}
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Walls, safe designs of, 721

Water, as reservoir of infections, 690--691, 716

Water conservation, as priority, 696

Water distribution, as priority, 692--696

 balance between scald prevention and microbial control, 694--695

 construction activities and, 695, 716

 decorative water features and, 695, 717

 disinfectant residual and, 692--694

 leaking pipes/condensation and, 695

 nonpotable water (process water) and, 692, 695--696, 716

 stagnation in pipes and, 692, 716

 thermostatic mixing valves/anti-scald devices and, 695

 water temperature and, 694

Water distribution systems, in health care facilities, as pathogen reservoir, 714--716

 building safety plans for, 703--705

 LD pneumonia related to, 701

Water management priorities, for health care facilities, 691--696

 conservation as, 696

 distribution and quality as, 692

 safety as, 692--696

 security as, 696

Water quality, as priority, 692--696

Water safety, as priority, 692--696

 balance between scald prevention and microbial control and, 694--695

 construction activities and, 695

 decorative water features and, 695, 717

 disinfectant residual and, 692--694

 leaking pipes/condensation and, 695

 nonpotable water (process water) and, 692, 695--696, 716

 stagnation in pipes and, 692, 716

 thermostatic mixing valves/anti-scald devices and, 695

 water temperature and, 694

  *Legionella pneumophilia* and, **689--712**. See also *Legionella pneumophilia.*

 outbreak investigations of, 666, 673--674

Water safety plans, building, 703--705

 decision points for, 703--704

  *Legionella* prevention plans in, 704--705

 stakeholders in, 704--705

 team approach to, 703--704

Water security, as priority, 696

Water supply, emergency, as priority, 696

Water uses, in health care, infection risks of, 692--694

Water utility systems, 690, 716

Waterborne pathogens, categorized by transmission routes, 690--691, 716

 in health care facilities, 716

 safety initiatives for. See *Water safety.*

 strength of evidence for, 714--715

 in outbreaks, 672--674

WGS (whole genomic sequencing), of outbreaks, 671

WHO. See *World Heathcare Organization (WHO).*

Whole genomic sequencing (WGS), of outbreaks, 671

Whole surveillance, 578

Wipes, disposable, for environmental surface disinfection, 649

Wireless sensors, in hand hygiene compliance, 598, 601

Work restrictions, post-exposure, for HCP, 732, 748--750

 of conjunctivitis, 748

 of cytomegalovirus, 748

 of diarrheal diseases, 748

 of diphtheria, 748

 of group A streptococcus, 749

 of hepatitis A, 748

 of hepatitis B, 748

 of hepatitis C, 748

 of herpes simplex, 748

 of HIV, 748

 of measles, 748

 of meningococcal infections, 748

 of MRSA, 749

 of mumps, 749

 of pertussis, 749

 of rubella, 749

 of tuberculosis, 749

 of varicella, 749

 of viral respiratory tract infections, 749

 of zoster, 749

World Heathcare Organization (WHO), hand hygiene guidelines/indications of, 600, 651, 789

 on alternative health care settings, 787

 on HAIs in developing countries, 806, 808--810, 812
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=

*Yersinia enterocolitica,* outbreak investigations of, 669

Z {#sec24}
=

Zero rates, of HAIs, 570

Zoster, in HCP, work restrictions for, 749
